Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
OCIAD1-AS1: OCIAD1-AS1 is an immune-related long non-coding RNA (lncRNA) that has been identified in several studies as a potential prognostic marker for bladder cancer (BLCA) [PMC9881817] [PMC9827344] [PMC8828980] [PMC8413054] [PMC9794272] [PMC9393225] [PMC8635160]. It is one of the lncRNAs included in prognostic signatures for BLCA patients, along with other lncRNAs such as USP30-AS1, LINC02321, PSMB8-AS1, KRT7-AS, and LINC01767 [PMC9827344]. The expression of OCIAD1-AS1 has been found to be significantly lower in BLCA cell lines [PMC8828980]. Additionally, OCIAD1-AS1 has been associated with the regulation of GPM6B/AKAP11 and the interaction with miR-141-3p and miR-200a-3p in bladder cancer mechanisms [PMC9393225]. It has also been included in a predictive model for bladder cancer patients along with other pyroptosis-related lncRNAs such as SNHG18, SLC25A25-AS1, MAFG-DT, TRIM31-AS1, and PSMB8-AS1 [PMC9393225]. Furthermore, OCIAD1-AS1 has been identified as a protective factor for bladder cancer patients with HR < 1 and high expression levels of OCIAD1-AS1 have shown better overall survival rates compared to low expression levels [PMC9393225].
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset